Effects of high-dose intravenous gammaglobulin on kinetic parameters of 51Cr-labelled platelets in chronic ITP
Grossi, A.; Vannucchi, A.M.; Casprini, P.; Morfini, M.; Ferrini, P.R.
Haematologica 71(2): 123-127
1986
ISSN/ISBN: 0390-6078 PMID: 2424812 Document Number: 282200
Document emailed within 1 workday
Related Documents
Craig, T.J.; Davis, W. 1993: Hepatitis associated with high dose intravenous gammaglobulin Annals of Allergy 71(3): 276Gibson, J.; Laird, P.P.; Joshua, D.E.; Child, A.; Harris, J.; Kronenberg, H. 1989: Very high dose intravenous gammaglobulin in thrombocytopenia of pregnancy Australian and New Zealand Journal of Medicine 19(2): 151-153
Sultan, Y.; Kazatchkine, M.D.; Maisonneuve, P.; Nydegger, U.E. 1984: Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin Lancet 2(8406): 765-768
Jordan, S.C.; Quartel, A.W.; Czer, L.S.; Admon, D.; Chen, G.; Fishbein, M.C.; Schwieger, J.; Steiner, R.W.; Davis, C.; Tyan, D.B. 1998: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation 66(6): 800-805
Frankel, S.J.; Polmar, S.H.; Grumet, F.C.; Wedner, H.J. 1986: Anti-IgA antibody associated reactions to intravenous gammaglobulin in a patient who tolerated intramuscular gammaglobulin Annals of Allergy 56(5): 436-439
Kawada, K.; Terasaki, P.I. 1987: Evidence for immunosuppression by high-dose gammaglobulin Experimental Hematology 15(2): 133-136
Brearley, R.L.; Rowbotham, B. 1984: High-dose gammaglobulin for idiopathic thrombocytopenic purpura Australian and New Zealand Journal of Medicine 14(1): 67-68
Guaschino, R.; Alesso, D.; Olliaro, P.; Mazzucco, L. 1985: Plasma-exchange plus high-dose intravenous gamma globulin for chronic thrombocytopenic purpura International Journal of Artificial Organs 8(3): 169
Becker, W.; Marienhagen, J.; Ordnung, D.; Wolf, F. 1990: Kinetic of Tc-99m-anti-NCA-95-Moab in vitro labelled granulocytes in comparison to in-vivo Moab-labelled and In-111-oxine-labelled granulocytes Progress in Clinical and Biological Research 355: 151-158
Müting, D.; Dohn, P.; Reikowski, J. 1972: Effect of high-dose, intravenous and oral administration of essential phospholipids on protein and lipid metabolism as well as enzyme activities in patients with chronic liver disease Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1389-1392
Alfonso, J.; Gralla, J.; Klem, P.; Chan, L.; Wiseman, A.C.; Cooper, J.E. 2014: High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported Cohorts Clinical Transplants 2014: 161-170
Petukhov, V.I.; Bondare, D.K.; Baravika, I.Ia.; Velik, L.V. 1981: Kinetic parameters of proliferating granulocytes in patients with chronic myeloid leukemia Terapevticheskii Arkhiv 53(9): 39-45
Schiff, R.I. 1992: Indications for the use of intravenous gammaglobulin Annals of Allergy 68(6): 447-451
Sominskii, V.N.; Sokovnin, V.M.; Okun' K.V. 1988: Kinetic parameters of interaction of propranolol with the erythrocyte membrane in persons with different antihemolytic effects of this drug Kosmicheskaia Biologiia i Aviakosmicheskaia Meditsina 22(3): 86-88
Taneichi, H.; Miyawaki, T. 2011: High-dose intravenous immunoglobulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 69(3): 515-519
Korsak, J.; Zaleska, B.; Orłowska, E.; Kotowicz, J. 2005: Use of high dose intravenous immunoglobulin in neurologic disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(109): 98-101
Philalithis, P.E.; Joekes, A.M. 1974: High dose intravenous prednisolone in the treatment of glomerulonephritis Journal d'Urologie et de Nephrologie 80(12): 983-984
Armenta, D.; Espallargas, C.; Paz, A.; Rodríguez Martorel, J.; Ladines, R.; Alvarez, C.; Román, J.; Andrés, P. 1996: Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan Sangre 41(6): 465-467
Fain, O.; Eclache, V.; Sitbon, M.; Thomas, M. 1996: Aseptic meningitis during treatment with high-dose intravenous immunoglobulins Presse Medicale 25(13): 643
Greenblatt, D.J.; Ehrenberg, B.L.; Gunderman, J.; Scavone, J.M.; Tai, N.T.; Harmatz, J.S.; Shader, R.I. 1989: Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam Journal of Pharmacology and Experimental Therapeutics 250(1): 134-140